Middle East & Africa Generic Pharmaceuticals Market Size & Outlook
Middle East & Africa generic pharmaceuticals market, 2018-2028 (US$M)
Related Markets
MEA generic pharmaceuticals market highlights
- The MEA generic pharmaceuticals market generated a revenue of USD 12.4 million in 2020.
- The market is expected to grow at a CAGR of 6.1% from 2021 to 2028.
- In terms of segment, simple generic was the largest revenue generating type in 2020.
- Biosimilars is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2021 to 2028.
MEA data book summary
| Market revenue in 2020 | USD 12.4 million |
| Market revenue in 2028 | USD 19.9 million |
| Growth rate | 6.1% (CAGR from 2020 to 2028) |
| Largest segment | Simple generic |
| Fastest growing segment | Biosimilars |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Simple Generic, Specialty Generics, Biosimilars |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Viatris Inc, Novartis AG ADR, Sun Pharmaceutical Industries, Lupin, AbbVie Inc, AstraZeneca PLC, Sawai Group Holdings Co Ltd, Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd ADR, Cipla Ltd DR, Sanofi SA, Aurobindo Pharma, Endo Pharmaceuticals |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.0% of the global generic pharmaceuticals market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 178.7 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Generic Pharmaceuticals Market Scope
Generic Pharmaceuticals Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa generic pharmaceuticals market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to generic pharmaceuticals market will help companies and investors design strategic landscapes.
Simple generic was the largest segment with a revenue share of 78.23% in 2020. Horizon Databook has segmented the Middle East & Africa generic pharmaceuticals market based on simple generic, specialty generics, biosimilars covering the revenue growth of each sub-segment from 2018 to 2028.
Reasons to subscribe to Middle East & Africa generic pharmaceuticals market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa generic pharmaceuticals market databook
-
Our clientele includes a mix of generic pharmaceuticals market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa generic pharmaceuticals market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa generic pharmaceuticals market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
MEA generic pharmaceuticals market size, by country, 2018-2028 (US$M)
Middle East & Africa Generic Pharmaceuticals Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
